首页> 美国卫生研究院文献>Oncotarget >Selective targeting of KRAS-Mutant cells by miR-126 through repression of multiple genes essential for the survival of KRAS-Mutant cells
【2h】

Selective targeting of KRAS-Mutant cells by miR-126 through repression of multiple genes essential for the survival of KRAS-Mutant cells

机译:miR-126通过抑制多个对KRAS-Mutant细胞生存至关重要的基因而选择性靶向KRAS-Mutant细胞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

MicroRNAs (miRNAs) regulate the expression of hundreds of genes. However, identifying the critical targets within a miRNA-regulated gene network is challenging. One approach is to identify miRNAs that exert a context-dependent effect, followed by expression profiling to determine how specific targets contribute to this selective effect. In this study, we performed miRNA mimic screens in isogenic KRAS-Wild-type (WT) and KRAS-Mutant colorectal cancer (CRC) cell lines to identify miRNAs selectively targeting KRAS-Mutant cells. One of the miRNAs we identified as a selective inhibitor of the survival of multiple KRAS-Mutant CRC lines was miR-126. In KRAS-Mutant cells, miR-126 over-expression increased the G1 compartment, inhibited clonogenicity and tumorigenicity, while exerting no effect on KRAS-WT cells. Unexpectedly, the miR-126-regulated transcriptome of KRAS-WT and KRAS-Mutant cells showed no significant differences. However, by analyzing the overlap between miR-126 targets with the synthetic lethal genes identified by RNAi in KRAS-Mutant cells, we identified and validated a subset of miR-126-regulated genes selectively required for the survival and clonogenicity of KRAS-Mutant cells. Our strategy therefore identified critical target genes within the miR-126-regulated gene network. We propose that the selective effect of miR-126 on KRAS-Mutant cells could be utilized for the development of targeted therapy for KRAS mutant tumors.
机译:MicroRNA(miRNA)调节数百种基因的表达。但是,在miRNA调控的基因网络中鉴定关键靶标具有挑战性。一种方法是鉴定发挥上下文相关作用的miRNA,然后进行表达谱分析以确定特定靶点如何促进这种选择性作用。在这项研究中,我们在等基因KRAS野生型(WT)和KRAS突变型结肠直肠癌(CRC)细胞系中进行了miRNA模拟筛选,以鉴定选择性靶向KRAS突变型细胞的miRNA。我们确定为多种KRAS-Mutant CRC细胞存活的选择性抑制剂的miRNA之一是miR-126。在KRAS突变细胞中,miR-126过表达增加了G1区室,抑制了克隆形成性和致瘤性,而对KRAS-WT细胞没有影响。出乎意料的是,miR-126调节的KRAS-WT和KRAS-Mutant细胞转录组没有显着差异。然而,通过分析miR-126靶标与RNAi在KRAS-Mutant细胞中鉴定的合成致死基因之间的重叠,我们鉴定并验证了KRAS-Mutant细胞的存活和克隆性选择性需要的miR-126调控基因的子集。因此,我们的策略在miR-126调控的基因网络中确定了关键的靶基因。我们提出,miR-126对KRAS突变细胞的选择性作用可用于KRAS突变肿瘤靶向治疗的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号